Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 50090-5822

7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50090-5822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl500905822)

Label Image (Lbl500905822)
Packaging label for oxybutynin chloride 5 mg extended-release tablets by A-S Medication Solutions. The label indicates an oral tablet with 90 extended-release tablets per package, including storage instructions to keep at 77 degrees Fahrenheit and protect from moisture. The product NDC is 50090-5822.*
FDA Label Image

Figure 1 (Oxybutynin Fig 1)

Figure 1 (Oxybutynin Fig 1)
A line graph showing mean plasma R-Oxybutynin concentration (ng/mL) over 24 hours. It compares two dosing regimens of oxybutynin: extended-release 10 mg once daily (QD) and 5 mg three times daily (TID). The y-axis represents concentration, and the x-axis indicates time in hours, with error bars illustrating variability at each time point.*
FDA Label Image

Figure 2 (Oxybutynin Fig 2)

Figure 2 (Oxybutynin Fig 2)
A line graph showing mean R-Oxybutynin plasma concentration (ng/mL) over time (hours), ranging from 0 to 24 hours with plotted points indicating values and error bars representing variability at each time point.*
FDA Label Image

Figure 3 (Oxybutynin Fig Study 1)

Figure 3 (Oxybutynin Fig Study 1)
A horizontal bar chart comparing the mean change in episodes per week from baseline for oxybutynin extended release (ER) and placebo groups. The chart includes error bars indicating standard deviation for each group, with the mean change values displayed along a horizontal axis ranging from -40 to 40.*
FDA Label Image

Figure 4 (Oxybutynin Fig Study 2)

Figure 4 (Oxybutynin Fig Study 2)
A horizontal bar chart showing mean change (±SD) in episodes per week from baseline comparing oxybutynin ER and oxybutynin. The x-axis ranges from -40 to 40, with no positive mean change shown. Oxybutynin ER shows a more negative mean change than oxybutynin, indicating a greater reduction in episodes.*
FDA Label Image

Figure 5 (Oxybutynin Fig Study 3)

Figure 5 (Oxybutynin Fig Study 3)
A horizontal bar chart showing the mean change (±SD) in episodes per week from baseline for oxybutynin ER and oxybutynin. The x-axis ranges from -40 to 40, with data bars indicating reductions in episodes per week for both treatments.*
FDA Label Image

Chemical Structure (Oxybutynin Struc)

Chemical Structure (Oxybutynin Struc)
Chemical structure of oxybutynin chloride, showing its molecular arrangement including a cyclohexyl group, a phenyl ring, and a side chain with a nitrogen atom bonded to ethyl groups and associated with hydrochloride (HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.